auto_awesome
Want to know who else bid on this?
Proposal Forge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Recipient
iProgen Biotech Inc.Department
National Research Council CanadaAmount
$600.0K
Province
BCType
Contribution
Agreement Number
172-2019-2020-Q3-939055
Purpose
CIIP Korea project NextGenADC will integrate the protein engineering expertise and enhanced antibody delivery technology of iProgen Biotech Inc. (Canada) with the unique linker-payload and site-specific conjugation technologies of AbTis Co., Ltd. (Korea). Together, this international partnership aims to create a next generation antibody-drug conjugate (ADC) as a potential therapeutic agent with a superior efficacy and safety profile for treating patients with solid tumours.
iProgen Biotech Inc. × National Research Council Canada
15 grants totalling $3.5M
Canadian International Innovation Program
132 grants totalling $54.2M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| 7423463 Manitoba Ltd. | $600.0K | Canadian International Innovation Progra... |
| Optiwave Systems Inc. | $600.0K | Canadian International Innovation Progra... |
| Canadian Health Solutions Inc. | $600.0K | Canadian International Innovation Progra... |
| Precision Microdynamics Inc. | $600.0K | Canadian International Innovation Progra... |
| Feldan Bio inc. | $600.0K | Canadian International Innovation Progra... |